FDA investigates reports of hair loss, suicidal thoughts in people using popular diabetes, weight loss drugs
The Food and Drug Administration (FDA) is looking into reports of adverse side effects from using diabetes medications such as Ozempic and Mounjaro, with hair loss, suicidal thoughts and airway obstruction being among the reported complications. According to the latest information from the agency, the FDA Adverse Event Reporting System (FAERS) received reports of patients…
Source: yahoo.com
